NS Reader
Benefits
NS Reader
Features
NS Reader
Specification
NS Reader
No products in the cart.
NS Reader
Benefits
NS Reader
Features
NS Reader
Specification
NS Reader
Orders made at Medpick are initiated and processed for shipment upon receipt of request from the customer. Please note that our Shipping Services (Fee, Transportation, Loss or Damage of any shipment, etc.) are in accordance with the Seller\'s terms of Shipment.
Please refer to Medpick Return Policy.
Please refer to Medpick Return Policy.
Cystic Fibrosis (CF) is an autosomal recessive disorder affecting the lungs, pancreas, intestine and liver. CF is the most common in Caucasians with an incidence rate 1:2500 newborns. CF is caused by mutation in the gene for the protein cystic fibrosis transmembrane conductance regulator (CTFR) [1,2]. Large-scale neonatal screening for CF is performed by indentification of increased levels of immunoreactive trypsinogen (IRT) in blood.
Labsystems Diagnostics’ Neonatal Toxoplasma gondii IgM FEIA is a fluorometric enzyme immunoassay intended for the determination of IgM-class antibodies to Toxoplasma gondii in blood samples dried on filter paper. The test is intended as a primary method for screening newborns for congenital toxoplasmosis (CT).
Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is the most common human enzyme deficiency; an estimated 400 million people worldwide are affected by this enzymopathy (6). With regards to the demographics of G6PD deficiency, most of the affected individuals reside in Africa, the Middle East, and Southeast Asia. The G6PD enzyme catalyzes an oxidation/reduction reaction.
Sign up for Insider Pricing and get access to attractive discounted prices on commercially rated products as well as dedicated Account Representatives to manage your orders.
Sign up for Insider Pricing and get access to attractive discounted prices on commercially rated products as well as dedicated Account Representatives to manage your orders.